Citation tools
"MITIGATE-NeoBOMB1, a Phase I/IIa Study to Evaluate Safety, Pharmacokinetics, and Preliminary Imaging of 68Ga-NeoBOMB1, a Gastrin-Releasing Peptide Receptor Antagonist, in GIST Patients." Journal of Nuclear Medicine
61.12
(2020):
1749-1755.
Web. 19 April. 2024.